Full Length Research Paper
References
Abdel Razak O, Belal F, Bedair M, Barakat S, Haggag S (2003). Spectrophotometric and polarographic determination of enalapril and Lisinopril using 2, 4-dinitrofluorobenzene. J. Pharm. Biomed. Anal. 31:701-711. crossref |
||||
Asad R, Tariq A, Atta-ur-R (2005). Spectrophotometric determination of Lisinopril in Pure and Pharmaceutical Formulations. J. Chin. Chem. Soc. 52(5):1055-1059. | ||||
Avadhanutu B, Pantulu R (1993). Gas liquid chromatographic estimation of lisinopril in its pharmaceutical dosage forms. Indian Drugs 30:646-649. | ||||
Basavaiah K, Tharpa K, Vinay KB (2010). Titrimetric assay of lisinopril in aqueous and non-aqueous media. Eclética Quím. 35(2):7-14. crossref |
||||
British Pharmacopoeia (2009). British Pharmacopoeia, HM Stationary Office: London. pp. 1135-1138. | ||||
Čakar M, Popović G (2012). Determination of lisinopril in pharmaceuticals by a kinetic spectrophotometric method. J. Serb. Chem. Soc. 77(10):1437-1442. crossref |
||||
Constantinos Z, Paraskevas T, Demtrius T, Georgios T, Anastasios E, Pantelis R (2004). Rapid spectrofluorimetric determination of lisinopril in pharmaceutical tablets using sequential injection analysis. Anal. Bioanal. Chem. 379:759-763. | ||||
Devi PA, Mallikarjuna Rao GPV, Krishna Prasad KMM, Sastry CSP (2003). Four simple spectrophotometric determinations of lisinopril in pure state and in tablets. Indian J. Pharm. Sci. 65(3):296-99. | ||||
Dinc S, Donmez OA, Asci Burge, Bozdogan A (2013). Spectrophotometric multicomponent resolution of a tablet formulation containing lisinopril and hydrochlorothiazide by multivariate calibration methods. Asian J. Chem. 25(2):999-1002. | ||||
El-Enany N, Belal F, Al-Ghannam S. (2003). Polarographic determination of lisinopril in pharmaceuticals and biological fluids through treatment with nitrous acid. Microchim. Acta 141:55-61. crossref |
||||
El-Gindy A, Ashour A, Abdel-Fattah L, Shabana MM (2001) Spectrophotometric, septrofluorimetric and LC determination of lisinopril. J. Pharm. Biomed. Anal. 25:913-922. crossref |
||||
El-Yazbi FA, Abdine HH, Shaalan RA (1999). Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage forms. J. Pharm. Biomed. Anal. 19:819-827. crossref |
||||
Esra S, Aktas L, Lale E, Olcay S (2003). A new spectrofluorimetric method for the determination of lisinopril in tablets. IL Farmacol. 58:165-168. crossref |
||||
Gotti R, Andrisano V, Cavrini V, Bertucci C, Furlanetto S (2000). Analysis of ACE-inhibitors by CE using alkylsulfonic additives. J. Pharm. Biomed. Anal. 22:423-31. crossref |
||||
Hall J, Guyton E, Arthur C (2006). The textbook of medical physiology. St. Louis, Mo., Elseivier Saunders. P 228. | ||||
Ike SO (2009). "Prevalence of hypertension and its complications among medical admissions at the University of Nigeria teaching hospital, Enugu (Study 2)." Niger. J. Med. 18(1):68-72. Pubmed |
||||
Ivanovic D, Medenica M, Jancic B, Knezevic N, Malenovic A, Milic J (2007). Validation of an analytical procedure for simultaneous determination of hydrochlorothiazide, lisinopril, and their impurities. Acta Chromatogr. 18:143-156. | ||||
Jamakhandi CM, Javali C, Kumar S, Kumar DS. (2010). New fluorimetry method of determination for lisinopril dosage forms. Int. J. Pharm. Sci. Drug Res. 2(3):182–187. | ||||
Japanese Pharmacopoeia (1993). 15th Edition. Pharmaceuticals and Medical Devices Agency Chiyoda-ku, Tokyo 100-0013 Japan. | ||||
Jegede EC (1998). Drug regulation and control in developing countries. Buffalo Groove II, Interpharm Press Inc. pp. 35-37. | ||||
Kolo PM, Jibrin YB, Sanya EO, Alkali M, Peter Kio IB, Moronkola RK (2012). Hypertension-related admissions and outcome in a tertiary hospital in Northeast Nigeria. Int. J. Hypertens. pp. 1-6. crossref |
||||
Olaniyi AA (1993). Towards better quality assurance of drugs and foods. Proceedings of a National Workshop, 1993. Department of Pharmaceutical Chemistry, University of Ibadan. pp. 67-72. | ||||
Pungal A (2013). Simple titrimetric method for the estimation of salbutamol sulphate (SBS) in pharmaceutical formulations. Res. J. Pharm. Sci. 2(1):11-14. | ||||
Raghu MS, Basavaiah K, Prashanth KN, Vinay KB (2012). Acid-base titrimetric assay of pheniramine maleate in pharmaceuticals in hydro-alcoholic medium. Der. Pharmacia. Lett. 4(5):1523-1529. | ||||
Rajendraprasad N, Basavaiah K, Vinay KB (2013). Acid-base titrimetric assay of hydroxyzine dihydrochloride in pharmaceutical samples. Chem. Ind. Chem. Eng. Q. 16(2):127-132. | ||||
Sagirli O, Ersoy L (2004). An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection. J. Chromatogr. 809(1):159-165. | ||||
Shinde V, Trivedi A, Upadhayay PR, Gupta NL, Kanase DG, Chikate R (2007). Identification of a new impurity in lisinopril. J. Pharm. Biomed. Anal. 43(1):381-86. crossref |
||||
Stanisz B (2004). Estimation of the applicability of differential spectroscopic method for the determination of lisinopril in tablets and for the evaluation of its stability. Acta Pol. Pharm. Drug Res. 61(5):327–334. | ||||
Ukoh VA (2007). Admission of hypertensive patients at the University of Benin teaching hospital, Nigeria. East Afr. Med. J. 84(7):329–335. Pubmed |
||||
United States Pharmacopoiea-USP-24, NF-19 (2000). Asian Edition, United States Pharmacopoeial Convention, Inc. Twin Brook Parkway, Rockville, MD, U.S.A. | ||||
Widimsky J (2009). The combination of an ace inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension. Soc. Hypertens. J. 55(2):123-130. | ||||
WHO (1996). World Health Organization Expert Committee on specifications for Pharmaceutical Preparations, 34th Report. WHO Technical Report Series, No. 863. Geneva, Switzerland. | ||||
Yuan AS, Gilbert JD (1996). Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum. J. Pharm. Biomed. Anal. 14:773-81. crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0